Article
Carriage of rare APOB variants predisposes to severe steatotic liver disease and hepatocellular carcinoma.
The Journal of clinical investigation - 15 Apr 2026
Mureddu Matteo, Pelusi Serena, Jamialahmadi Oveis, Vujkovic Marijana, Miano Lorenzo, Eidgah Torghabehei Hadi, Ronzoni Luisa, Malvestiti Francesco, Saracino Marco, Periti Giulia, Moretti Vittoria, Teerlink Craig C, Lynch Julie A, Tsao Philip S, Johnson Josephine P, La Mura Vincenzo, Dilena Robertino, Alqahtani Saleh A, Cherubini Alessandro, Russo Francesco Paolo, D'Ambrosio Roberta, Fraquelli Mirella, Petta Salvatore, Miele Luca, Vespasiani-Gentilucci Umberto, Bugianesi Elisabetta, Mancina Rosellina M, Parini Paolo, Prati Daniele, Chang Kyong-Mi, Schneider Carolin V, Romeo Stefano, Valenti Luca Vc
Abstract excerpt
BACKGROUNDMetabolic dysfunction-associated steatotic liver disease (MASLD) has a substantial inherited component. Rare variants in apolipoprotein B gene (APOB) have been implicated in susceptibility to liver steatosis, but their role in disease progression and outcomes is unclear.METHODSWe investigated APOB rare variants in a case-control cohort of people with advanced MASLD versus healthy controls (n = 510 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
